Molecular Pharmacology (usa)
(OTC) MLPH
Molecular Pharmacology (usa) Financials at a Glance
Market Cap
$799,600
Revenue (TTM)
$0.00
Net Income (TTM)
$7.21K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-16.30 (Low)
Dividend
$0.00
Beta (Volatility)
-16.30 (Low)
Price
$0.00
Volume
238
Open
$0.00
Price
$0.00
Volume
238
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
-16.30 (Low)
Price
$0.00
Volume
238
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
MLPH News
MLPH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Molecular Pharmacology (usa)
Industry
Pharmaceuticals
Sector
Health CareCEO
Xin Shi
Website
www.mpl-usa.comHeadquarters
Perth, WA 6007, AU
MLPH Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
0%
Return on Assets
0%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$799.60K
Shares Outstanding
999.55M
Volume
238
Short Interest
0.00%
Avg. Volume
35.40K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$5.52K
EBITDA
$5.52K
Operating Cash Flow
$105.41K
Capital Expenditure
$0.00
Free Cash Flow
$105.41K
Cash & ST Invst.
$2.38K
Total Debt
$0.00
Molecular Pharmacology (usa) Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$799.60K
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$600.00
+62.5%
EBITDA
$600.00
+62.5%
Quarterly Fundamentals
Net Cash
$1.52K
-78.8%
Accounts Receivable
$7.33K
+35.1%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
0.00%
N/A
Return on Invested Capital
0.00%
N/A
Free Cash Flow
$32.28K
-13.9%
Operating Cash Flow
$32.28K
-13.9%